Patent: 7,815,936
✉ Email this page to a colleague
Summary for Patent: 7,815,936
Title: | Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
Abstract: | The use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions, the pharmaceutical compositions per se, as well as an adsorbate consisting of the granular material and at least one further substance selected from pharmaceutical active constituents and auxiliary substances, and the production of such adsorbates, are described. |
Inventor(s): | Hasenzahl; Steffen (Hanau, DE), Meyer; Jurgen (Stockstadt, DE), Heym; Jurgen (Horstein, DE) |
Assignee: | Evonik Degussa GmbH (Essen, DE) |
Application Number: | 10/281,223 |
Patent Claims: | see list of patent claims |
Details for Patent 7,815,936
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 10/28/1982 | ⤷ Try a Trial | 2021-10-30 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 12/29/2015 | ⤷ Try a Trial | 2021-10-30 |
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 08/06/1998 | ⤷ Try a Trial | 2021-10-30 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 03/31/1994 | ⤷ Try a Trial | 2021-10-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |